SEC Company Response from Beam Therapeutics Inc. (BEAM) (CIK 0001745999) (BEAM) — Feb 3, 2020
Beam Therapeutics Inc. (BEAM) (CIK 0001745999)
Date: Feb. 3, 2020 · CIK: 0001745999 · Accession: 0001193125-20-022634
AI Filing Summary & Sentiment
File numbers found in text: 333-233985
Show Raw Text
CORRESP 1 filename1.htm Company Acceleration Request BEAM THERAPEUTICS INC. 26 Landsdowne Street Cambridge, Massachusetts 02139 February 3, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Tonya Aldave Re: Beam Therapeutics Inc. Registration Statement on Form S-1 (File No. 333-233985) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Beam Therapeutics Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on February 5, 2020, or as soon as possible thereafter. The Company hereby authorizes Marc Rubenstein or Thomas Danielski of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. Please call Thomas Danielski of Ropes & Gray LLP, counsel to the Company, at (617) 235-4961 as soon as the registration statement has been declared effective. [Signature page follows] Very truly yours, BEAM THERAPEUTICS INC. By: /s/ John Evans Name: John Evans Title: Chief Executive Officer Signature Page to Acceleration Request